CoreAge Rx GLP-1 Review: $99 a Month, If You Pay Twelve Months Up Front

The flat-dose pricing idea is genuinely good, and the way it is presented needs unpicking. What the site promises. "Most GLP-1 programs start you at a low price. Then your dose increases — and your bill doubles. Sometimes triples. With CoreAge Rx, $149 is $149. On every dose. Every month. Forever." That criticism of the category is accurate. Dose-tiered pricing is the standard structure in compounded GLP-1 telehealth, and it does mean the advertised entry price is not what most patients pay by month four, because GLP-1 dosing escalates by design. A genuinely flat price across doses is a real consumer benefit and worth crediting. What the footnote says. "Prices shown are starting at, based on a 12-month plan paid in full." So the arithmetic is: Semaglutide at $99/month × 12 = $1,188, paid at the start. Tirzepatide at $149/month × 12 = $1,788, paid at the start. Two problems follow. First, "No Commitment" and "12-month plan paid in full" cannot both describe the same offer. The phrase "Start Your Online Visit — Takes 3 Minutes • No Commitment" appears near the pricing; the twelve-month prepayment requirement appears in small print at the bottom. A reader who does not scroll to the footer will not know. Second, and more importantly: GLP-1 treatment frequently does not last twelve months. Discontinuation rates in real-world use are substantial — side effects, cost, supply, or simply deciding it is not for you. Prepaying a year of a medication you may stop in month two is a materially different risk from paying monthly, and it makes the refund policy the single most important term in the entire offer. What we could not verify and you must establish before paying: What happens to the unused portion if you stop. Is it refunded pro rata, refunded at all, or forfeited? A Returns & Refund page exists — read it in full before you pay anything. Whether a monthly option exists, and at what price. A page reference to "from $199/mo" appears in the weight loss section alongside the $99 and $149 figures, which suggests different plan lengths carry different rates. Ask directly what the month-to-month price is. Whether the price is guaranteed at renewal. Ask those three questions on the phone or in writing before entering a card. Everything else in this review is secondary to them.

CoreAge Rx discloses this correctly on its own site, and it deserves to be understood rather than skimmed. Its own wording: "Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness." That statement is accurate, and here is what follows from it. Compounded semaglutide is not Ozempic or Wegovy. Compounded tirzepatide is not Mounjaro or Zepbound. They share an active ingredient. They are not generics — no generic of either exists — and they have not been shown to be therapeutically equivalent to the branded products. No FDA review of the specific product. The FDA does not assess a compounded preparation's safety, effectiveness or manufacturing quality before it reaches you. The compounding pharmacy's own quality system is the control, and its standard varies. The efficacy figures you have read come from trials of the branded drugs. The published weight loss results for semaglutide and tirzepatide were produced in randomised trials of the FDA-approved products at defined doses. Those results do not automatically transfer to a compounded preparation, and any provider quoting them should be read with that in mind. Why compounded GLP-1s exist at all. Compounding of drugs on the FDA shortage list was widely permitted while semaglutide and tirzepatide were in shortage. Those shortages have been resolved, and FDA's position on compounding copies of commercially available drugs is restrictive. This is an area of active legal and regulatory dispute, and the supply landscape can change quickly. Ask what happens to your prepaid plan if the medication becomes unavailable. The comparison that reframes the whole category. Manufacturer-direct programmes now exist: LillyDirect offers Zepbound vials at published self-pay pricing. NovoCare Pharmacy offers Wegovy at published self-pay pricing, and substantially less with commercial insurance coverage. Both are the FDA-approved products, from the manufacturer, with full regulatory oversight. Check those prices before committing $1,188 or $1,788 to a compounded alternative. For some patients, particularly with insurance, the approved drug now costs less than the compounded one.

Two structural facts from the site's own legal text are worth reading carefully, because they are more informative than most of the marketing. LegitScript certification. The site states: "DSO Fine Shrimp LLC d/b/a CoreAge Rx is LegitScript-certified." This is a genuine positive. LegitScript runs a certification programme for telehealth and pharmacy websites, requiring evidence of licensing and compliant operation, and it is what major advertising platforms require before accepting healthcare advertising. It is checkable — you can search the LegitScript directory yourself, and doing so takes a minute. The clinical entity structure. The site states that all medical services — clinical evaluations, treatment planning and prescribing decisions — are provided exclusively by separate professional entities (MD Integrations and associated medical groups), which are independently owned and operated. This is the standard structure in US telehealth and it is worth understanding rather than being alarmed by. Most US states restrict the corporate practice of medicine, so the consumer-facing company and the entity employing the clinicians must be legally separate. What it means practically: Your prescriber works for the medical group, not for the brand you bought from. That separation is the point — it is meant to protect clinical judgement from commercial pressure. Complaints have two routes. Service and billing go to CoreAge Rx; clinical concerns go to the medical group, and ultimately to the state medical board that licenses your individual prescriber. Ask for your prescriber's name and licence number. You are entitled to know who is treating you, and you can verify any US clinician against their state board's public register. A service that makes this difficult is a service to avoid. Other stated credentials: evaluations by US board-certified physicians, fulfilment by registered pharmacies, a HIPAA-secure platform, same-day consultations, and US-only availability for residents aged 18 and over. What we could not verify: which compounding pharmacies are used, whether they are 503A or 503B facilities, and whether batch testing certificates are available on request. Ask. A 503B outsourcing facility registers with FDA and is subject to CGMP inspection; a 503A pharmacy compounds per individual prescription under state board oversight. That distinction is worth knowing for anything injectable.

CoreAge Rx sells more than GLP-1s, and the evidence base thins considerably outside them. This section is here because a reader signing up for weight loss will be offered these. NAD+ injections and nasal spray, from $93/month. Marketed for cellular energy and DNA repair. The honest position: there is no good controlled human evidence that NAD+ injections or nasal sprays improve energy, cognition or ageing outcomes. NAD+ biology is genuinely interesting and actively researched — the decline of NAD+ with age is real and mechanistically important. But interesting biology is not a demonstrated clinical benefit, and the delivery question is unresolved: NAD+ is a large molecule and how much of an injected or intranasal dose reaches the cells that matter is not established. We would not spend $1,116 a year on this. Sermorelin, from $99/month. A growth hormone releasing hormone analogue, marketed for lean muscle and growth hormone support. Sermorelin does raise growth hormone secretion — that part is real pharmacology. What is not established is that doing so in healthy adults produces meaningful benefits in body composition, energy or ageing. Growth hormone therapy in adults without diagnosed deficiency is not supported by evidence and carries real risks — insulin resistance, fluid retention, joint pain, carpal tunnel syndrome, and theoretical concerns around growth of existing malignancies. Diagnosed adult growth hormone deficiency is a specific endocrine condition confirmed by stimulation testing, not something identified from an online questionnaire. If you are being offered this without that workup, ask why. GLP-1 microdosing. Sub-therapeutic dosing marketed for metabolic benefit with fewer side effects. This has no trial evidence. The published efficacy data for semaglutide and tirzepatide comes from defined dose-escalation schedules to specific maintenance doses. A lower dose is not a validated protocol; it is an off-label practice with no outcome data. It may well produce fewer side effects — it will also produce less of whatever effect you were paying for. Supplements. Creatine, greens, fiber and a GLP-1 support product. Creatine is one of the best-evidenced supplements in existence for strength and lean mass. Greens powders and fiber are ordinary. Nothing here is a substitute for the prescription.

GLP-1 receptor agonists are effective medicines with a real side effect profile, and the eligibility questions matter. Do not use semaglutide or tirzepatide if you have: A personal or family history of medullary thyroid carcinoma, or Multiple Endocrine Neoplasia syndrome type 2. This is a boxed contraindication on the approved products, based on rodent thyroid C-cell tumour findings. A history of pancreatitis — discuss carefully with a clinician. Type 1 diabetes — these are not a substitute for insulin. Pregnancy, breastfeeding, or plans to conceive. These medicines should be stopped well in advance of a planned pregnancy; discuss timing with a clinician. Severe gastrointestinal disease including gastroparesis. Common side effects: nausea, vomiting, diarrhoea, constipation, abdominal pain, reduced appetite, fatigue and injection site reactions. These are most pronounced during dose escalation and are the most common reason people stop. Serious risks to know about: pancreatitis, gallbladder disease including gallstones, kidney injury from dehydration secondary to vomiting, and — a practical one that catches people out — delayed gastric emptying is relevant before any procedure requiring sedation or general anaesthesia. Tell your anaesthetist you are taking a GLP-1. Interactions: GLP-1s slow gastric emptying, which can affect absorption of oral medicines. This includes oral contraceptives — discuss backup contraception with your prescriber. If you take insulin or a sulfonylurea, dose adjustment may be needed to avoid hypoglycaemia. And the point people are not told at signup: weight regain after stopping is the norm, not the exception. The published follow-up data on these medicines shows substantial regain when treatment stops. This is a long-term treatment for a chronic condition, and the cost is therefore a long-term cost. Prepaying twelve months does not change that; it just front-loads one year of it. Availability: US residents aged 18 and over only.

How much does CoreAge Rx actually cost? Advertised from $99/month for compounded semaglutide and $149/month for compounded tirzepatide, with the site's own footer stating prices are based on a 12-month plan paid in full — $1,188 and $1,788 respectively. Ask for the month-to-month price. Is the price really the same at every dose? That is the company's stated promise, and flat-dose pricing is a genuine advantage over the dose-tiered structure common in this category. Confirm it in writing for the plan you buy. What if I stop after two months? This is the question to answer before paying. Read the Returns & Refund policy and get the pro-rata position in writing. Are the medications FDA-approved? No. They are compounded. The company states correctly that FDA does not review or approve compounded medications for safety or effectiveness. They are not generics and have not been shown to be therapeutically equivalent to the branded products. Is CoreAge Rx legitimate? The site states that DSO Fine Shrimp LLC d/b/a CoreAge Rx is LegitScript-certified, which is a real and checkable certification. Medical services are provided by separate professional entities (MD Integrations and associated medical groups), which is the standard US telehealth structure. Who is my actual doctor? A clinician employed by the medical group, not by CoreAge Rx. Ask for their name and state licence number and verify it on the state board register. Where is it available? US residents aged 18 and over. Should I consider the branded drugs instead? Check LillyDirect and NovoCare self-pay pricing for the FDA-approved products, and check your insurance. For some patients the approved drug now costs less than the compounded alternative. Is NAD+ or sermorelin worth adding? We would not. NAD+ injections and nasal sprays lack controlled human efficacy evidence, and growth hormone secretagogues are not appropriate for adults without diagnosed deficiency. Will I keep the weight off? Regain after stopping is the norm in the published data. Plan on this being long-term treatment.